1. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast;Angelova-Fischer;Acta Dermatovenerologica Alpina, Pannonica, et Adriatica,2005
2. Anonymous. (2012). FDA, Food and Drug Adminsitration. Highlights of Prescribing Information: Singulair (montelukast sodium) Tablets, Chewable Tablets, and Oral Granules. Initial U.S. Approval: 1998. [Revised by FDA]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021409s036lbl.pdf Accessed 28 May 2024.
3. The Physiological Basis of Veterinary Clinical Pharmacology;Baggot,2001
4. Recent advances in clinical development of leukotriene B4 pathway drugs;Bhatt;Seminars in Immunology,2017
5. Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends;Capra;Medicinal Research Reviews,2007